We are a multinational pharmaceutical group dedicated to improving the health and wellbeing of people in the markets we serve through the development, manufacture and marketing of a broad range of solid, liquid and injectable generic and in-licensed pharmaceutical products.
- 15-Apr-2008
- » Hikma Pharmaceuticals Launches “Hikma Global Volunteering Day”
- As part of Hikma Pharmaceuticals’ commitment to fulfilling its Corporate Social Responsibility (CSR) and in its firm belief in actively translating its Founder’s ethical principles into serving its communities in all its locations, Hikma has launched an annual Hikma Volunteering Day across its locations. This initiative reflects Hikma values as related to its involvement in local communities on a global scale as well as giving back to the communities.
- 18-Mar-2008
- » Hikma presents 2007 Preliminary results
- LONDON, 18 March 2008 - Hikma Pharmaceuticals PLC (“Hikma”) (LSE:HIK) (DIFX:HIK), the fast-growing multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of generic and in-licensed pharmaceutical products, across the Middle East and North Africa, the US and Europe, today reports its preliminary results for the year ended 31 December 2007.
